The cost effectiveness of empiric intravenous immunoglobulin for the antepartum treatment of fetal and neonatal alloimmune thrombocytopenia

Stephen F. Thung*, William A. Grobman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Fingerprint Dive into the research topics of 'The cost effectiveness of empiric intravenous immunoglobulin for the antepartum treatment of fetal and neonatal alloimmune thrombocytopenia'. Together they form a unique fingerprint.

Medicine & Life Sciences